Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Milestone Pharmaceuticals Inc. (MIST) had Debt to Capital Ratio of 0.80 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-41.52M |
|
-- |
|
-- |
|
$42.10M |
|
$-42.10M |
|
$0.58M |
|
$-41.52M |
|
$-41.52M |
|
$-41.52M |
|
$-41.52M |
|
$-41.52M |
|
$-41.52M |
|
$-42.10M |
|
$-42.00M |
|
62.21M |
|
62.21M |
|
$-0.67 |
|
$-0.67 |
|
| Balance Sheet Financials | |
$73.93M |
|
$0.20M |
|
$1.57M |
|
$75.50M |
|
$8.13M |
|
$53.35M |
|
$54.23M |
|
$62.35M |
|
$13.15M |
|
$13.15M |
|
$13.15M |
|
53.35M |
|
| Cash Flow Statement Financials | |
$-28.85M |
|
$8.28M |
|
$32.12M |
|
$13.76M |
|
$25.31M |
|
$11.55M |
|
$5.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.10 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.80 |
4.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-28.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-315.81% |
|
-315.81% |
|
-54.99% |
|
-62.44% |
|
$0.25 |
|
$-0.46 |
|
$-0.46 |
|